Request Deal Involvement

Yosemite led a $120m Round in Solve Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

KKH Advisors

pr advisors

KKH Advisors

or

Principals

YOSEMITE

bidder

YOSEMITE

B CAPITAL GROUP LP

bidder

B CAPITAL GROUP LP

SOLVE THERAPEUTICS

target

SOLVE THERAPEUTICS

ABINGWORTH MANAGEMENT

bidder

ABINGWORTH MANAGEMENT

ALLY BRIDGE GROUP

bidder

ALLY BRIDGE GROUP

BALYASNY ASSET MANAGEMENT LP

bidder

BALYASNY ASSET MANAGEMENT LP

SYMBIOSIS

bidder

SYMBIOSIS

MERCK & CO

bidder

MERCK & CO

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

AYURMAYA CAPITAL

bidder

AYURMAYA CAPITAL

GENERAL ATLANTIC LLC

bidder

GENERAL ATLANTIC LLC

SURVEYOR CAPITAL

bidder

SURVEYOR CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Yosemite led a $120m Round in Solve Therapeutics.